Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase

Vaccine

Volumn 21, Issue 1-2, 2002, Pages 60-66

  Yoshikawa, Tomoki ^a   Suzuki, Yujiro ^b   Nomoto, Akio ^c   Sata, Tetutaro ^a   Kurata, Takeshi ^a   Tamura, Shin Ichi ^a,d  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Antibody responses and protection; Congenic strains of mice; Hemagglutinin and neuraminidase; Influenza virus infection; Intranasal immunization

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; SIALIDASE; VIRUS HEMAGGLUTININ; IMMUNOLOGICAL ADJUVANT; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONGENIC STRAIN; CONTROLLED STUDY; DRUG EFFICACY; HAPLOTYPE; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROVOCATION TEST; UPPER RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS IMMUNITY; ANIMAL; CHEMISTRY; CLASSIFICATION; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INTRANASAL DRUG ADMINISTRATION; ORTHOMYXOVIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, CONGENIC; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 0037159627     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00434-6     Document Type: Article

References (41)

1. Lamb RA, Krug RM. Chapter 45 orthomyxoviridae: The viruses and their replication. In: Field BN, Knipe DN, Howley PM, et al., editors. Virology, 3rd Ed. Philadelphia: Lippincott-Raven Publishers; 1996. p. 1353-95.
2. Murphy BR, Webster RG. Chapter 46 Orthomyxoviruses. In: Field BN, Knipe DN, Howley PM, et al., editors. Virology, 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1996. p. 1397-445.
3. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:1990;737-771.
4. Hoskins T.W., Davies J.R., Smith A.J., Allchin A., Miller C.L., Pollck A.M. Influenza at Christ's Hospital: March, 1974. Lancet. 1:1976;105-108.
5. Meyer H.J., Hopps H.E., Parkman P.D., Ennis F.A. Review of existing vaccines for influenza. Am. J. Clin. Pathol. 0:1978;146-152.
6. Couch R.B., Kasel J.A. Immunity to influenza in man. Annu. Rev. Microbiol. 7:1983;529-549.
7. Underdown B.J., Schiff J.M. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4:1986;389-417.
8. Waldman R.H., Wigley F.M., Small P.A. Jr. Specificity of respiratory secretion antibody against influenza virus. J. Immunol. 05:1970;1477-1483.
9. Clements M.L., O'Donnell S., Levine M.M., Chanock R.M., Murphy B.R. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect. Immun. 40:1983;1044-1051.
10. Johnson P.R., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J. Infect. Dis. 154:1986;121-127.
11. Murphy B.R., Clements M.L. The systemic and mucosal immune response of humans to influenza A virus. Curr. Top. Microbiol. Immunol. 146:1989;107-116.
12. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:1984;350-356.
13. Tamura S.-I., Samegai Y., Kurata H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine. 6:1988;409-413.
14. Tamura S.-I., Asanuma H., Ito Y.et al. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur. J. Immunol. 22:1992;477-481.
15. Tamura S.-I., Ito Y., Asanuma H.et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J. Immunol. 149:1992;981-988.
16. Tamura S.-I., Yamanaka A., Shimohara M.et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine. 12:1994;419-426.
17. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today. 19:1998;89-97.
18. Ulmer J.B., Donnelly J.J., Parker S.E.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
19. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-xpressing plasmid DNA. Vaccine. 11:1993;957-960.
20. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine. 12:1994;1541-1544.
21. Webster R.G., Fynan E.F., Santoro J.C., Robinson H. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine. 12:1994;1495-1498.
22. Robinson H.L., Boyle C.A., Feltquate D.M., Morin M.J., Santoro J.C., Webster R.G. DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs. J. Infect. Dis. 1(Suppl.):1997;S50-S55.
23. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine. 15:1997;71-78.
24. Kodihalli S., Haynes J.R., Robinson H.L., Webster R.G. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J. Virol. 71:1997;3391-3396.
25. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., Webster R.G. M DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73:1999;2094-2098.
26. Fu T.M., Friedman A., Ulmer J.B., Liu M.A., Donnelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71:1997;2715-2721.
27. Chen Z., Sahashi Y., Matsuo K.et al. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine. 16:1998;1544-1549.
28. Chen Z., Matsuo K., Asanuma H. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine. 17:1999;653-659.
29. Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Kurata T., Tamura S.-I. Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine. 18:2000;3214-3222.
30. Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Sata T., Kurata T., Tamura S.-I. Protection against influenza B virus infection by immunization with DNA vaccines. Vaccine. 19:2001;1446-1455.
31. Chen Z., Yoshikawa T., Kadowaki S.et al. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J. Gen. Virol. 80:1999;2559-2564.
32. McKimm-Breschkin J.L., Caldwell J.B., Guthrie R.E., Kortt A.A. A new method for the purification of the influenza A virus neuraminidase. J. Virol. Method. 32:1991;121-124.
33. Gerentes L., Kessler N., Aymard M. A sensitive and specific ELISA immunocapture assay for rapid quantitation of influenza A/H3N2 neuraminidase protein. J. Virol. Method. 73:1998;185-195.
34. Tobita K., Sugiura A., Enomote C., Furuyama M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. (Berl). 162:1975;9-14.
35. Tobita K. Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses. Med. Microbiol. Immunol. (Berl). 162:1975;9-14.
36. Tamura S., Kurata H., Funato H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit. Vaccine. 7:1989;314-320.
37. Murphy BR. Mucosal immunity to viruses. In: Ogra PL, Lamm M.E, McGhee JR, Mestecky J, Strober W, Bienenstock J, editors. Handbook of Mucosal Immunology. San Diego (CA): Academic Press; 1994. p. 333-43.
38. Asahi Y., Yoshikawa T., Watanabe I.et al. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccine. J. Immunol. 168:2001;2930-2938.
39. Kilbourne E.D., Couch R.B., Kasel J.A., Johansson B.E.et al. Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. Vaccine. 13:1995;1799-1803.
40. Johansson B.E., Matthews J.T., Kilbourne E.D. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine. 16:1998;1009-1015.
41. Johansson B.E. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine. 17:1999;2073-2080.